GHS-R1a is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-09-09. Where a claim depends on a specific study, the study is described rather than over-claimed.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue class of compounds. Researchers at a pharmaceutical company first described it in the 1990s while screening small peptides for growth hormone releasing activity. Its chain contains five amino acid residues, two of which are non-natural building blocks, including 2-aminoisobutyric acid and a naphthylalanine derivative. The molecule was designed to act at the ghrelin receptor while avoiding several effects observed with earlier secretagogues.
At the cellular level, ipamorelin binds the growth hormone secretagogue receptor, also called the ghrelin receptor. Activation of this receptor on pituitary somatotroph cells triggers a signaling cascade that leads to release of growth hormone into circulation. Because release follows a pulsatile pattern, studies often report peak concentration and total area under the curve rather than a single time point. Selectivity for this receptor is the property most frequently discussed in comparative work.
杂质谱一般包含缺失序列片段、差向异构体、氧化产物以及残留溶剂或反离子，其中组氨酸与芳香残基的氧化常被重点关注。反相色谱中这类杂质往往紧邻主峰洗脱，因此方法需要足够的分离度并经过系统适用性验证。纯度百分比的解读依赖于检测波长与梯度条件，不同实验室公布的数字不宜直接横向比较。参考标准品有助于跨批次对照，但其自身赋值同样需要可追溯来源。
冻干状态下的肽通常比溶液状态更稳定，常规做法是维持 -20 °C 或更低温度、保持干燥并避开强光。复溶后的降解主要来自水解、氧化与脱酰胺，速率受 pH、缓冲液种类、离子强度与温度共同影响，碱性条件一般会加快这些反应。反复冻融会造成聚集与容器吸附损失，分装保存能降低该风险。容器材质与金属离子也可能参与氧化过程，需与操作条件一并考虑。
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic pentapeptide | Growth hormone secretagogue family |
| Sequence | Aib-His-D-2-Nal-D-Phe-Lys-NH2 | Contains two non-natural residues |
| Molecular formula | C38H49N9O5 | Free base form |
| Molecular weight | 711.85 g/mol | Calculated from formula |
| Primary target | GHS-R1a ghrelin receptor | Agonist activity |
Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue. Its sequence, Aib-His-D-2-Nal-D-Phe-Lys-NH2, combines three non-proteinogenic residues with a C-terminal amide. The N-terminal aminoisobutyric acid unit and the two aromatic D-amino acids distinguish it from peptides assembled only from standard L-amino acids. Its formula is C38H49N9O5, corresponding to an average mass near 711.9 Da. At neutral pH the molecule carries a net positive charge, a property that shapes its behaviour in chromatographic and electrophoretic systems.
The compound was developed at Novo Nordisk during the 1990s as part of a programme seeking secretagogues with improved selectivity. It was described in the peer-reviewed literature in 1998 alongside related pentapeptides from the same series. Investigators advanced it because it raised growth hormone output in animal models while leaving other pituitary hormones comparatively unaffected. The development code NNC 26-0161 appears in earlier reports, and ipamorelin later became the common designation in published work.
Selectivity is the property most often attached to this peptide. Published animal and early human studies record increases in growth hormone release after administration, with adrenocorticotropic hormone and cortisol responses remaining small by comparison. Effects on appetite-related pathways also appear weaker than those reported for several earlier secretagogues. Reviews that compare members of the growth hormone secretagogue family cite these findings frequently, though the receptor-level explanation for the selectivity continues to be debated rather than settled.
Storage recommendations for ipamorelin usually focus on temperature, moisture, and light. Lyophilized powder is typically held at or below minus twenty degrees Celsius in a desiccated container protected from light. Reconstituted solutions are often aliquoted and stored at minus eighty degrees Celsius to reduce repeated freeze-thaw cycles, which can promote aggregation or degradation. The optimal buffer and pH depend on the specific assay, and no single condition applies to every experimental context. Peptide stability should be assessed with time-point measurements rather than assumed from general handling rules.
In the scientific literature, ipamorelin appears mainly in preclinical studies, receptor binding assays, and reviews of growth hormone secretagogues. Authors often discuss its selectivity profile alongside limitations such as small sample sizes, short study durations, and differences between species. Some papers examine pharmacokinetics and clearance, but human data are limited and not sufficient to define general clinical effects. Regulatory discussion treats the compound as an investigational or research substance rather than an approved therapy in most jurisdictions. Open questions include oral bioavailability, long-term endocrine effects, and whether selectivity observed in animals persists in humans.
Research peptides such as ipamorelin are commonly supplied as lyophilized powder and characterized by analytical certificates. Reversed-phase high-performance liquid chromatography is used to estimate purity by ultraviolet absorbance, while mass spectrometry confirms molecular identity and detects sequence-related impurities. Counterion content, water content, and residual synthesis reagents can affect the reported mass balance. A certificate of analysis may list a purity percentage, but that number depends on the analytical method and the definition of impurity peaks. Independent verification is often recommended because research supply chains vary in quality control practices.
== Sources == Cole, R D (1996), "Choh Hao Li: April 21, 1913 - November 28, 1987", Biographical Memoirs of the National Academy of Sciences, vol. 70, pp. 221–39, PMID 11619324 Hruby, Victor J.; Yamashiro, Donald (1988), "Memorial issue in honor of Professor Choh Hao Li. Part I", Int. J. Pept. Protein Res, vol. 32, no. 6 (published Dec 1988), pp. 417–598, doi:10.1111/j.1399-3011.1988.tb01371.x, PMID 3073145 Hruby, V J (1988), "In memoriam Choh Hao Li, April 21, 1913-November 28, 1987", Int. J. Pept. Protein Res, vol. 31, no. 3 (published Mar 1988), pp. 253–4, PMID 3286549 "Classic pages in Obstetrics and Gynecology. Interstitial cell stimulating hormone. II. Method of preparation and some physico-chemical studies, by Choh Hao Li, Miriam E. Simpson, and Herbert M. Evans. Endocrinology, vol. 27, pp. 803–808, 1940", Am. J. Obstet. Gynecol, vol. 17, no. 5 (published Nov 1, 1973), p. 716, 1973, PMID 4599575 "Choh Hao Li", Triangle; the Sandoz Journal of Medical Science, vol. 9, no. 1, pp. 41–2, 1969, ISSN 0041-2597, PMID 4896971 Ingle, D J; Nezamis, J E; Moreley, E H; Li, C H (1953), "The effect of some partially purified preparations of corticotrophin upon the work performance of adrenalectomized-hypophysectomized rats", Acta Endocrinol, vol. 14, no. 2 (published Oct 1953), pp. 93–8, doi:10.1530/acta.0.0140093, PMID 13113828
=== Young Investigator (YI) Post-Doctoral Programme === (RCB-YI award) has been initiated to nurture outstanding recent PhDs with innovative ideas and the drive to pursue novel discoveries under the mentorship of RCB faculty. RCB-YI award has been instituted for both Indian and Foreign nationals on the competitive basis with initial appointment for three years which is extendable on rigorous review for additional two years.
This is because the use of UV fluorescence is reagentless, or a process that does not require an added chemical to produce a reaction, with no consumables, or produces no chemical byproducts. Additionally, TAC-BIO can reliably discriminate between threat and non-threat aerosols. It was claimed to be sensitive enough to detect low concentrations, but not so sensitive that it would cause false positives. The particle-counting algorithm used in the device converted raw data into information by counting the photon pulses per unit of time from the fluorescence and scattering detectors, and comparing the value to a set threshold. The original TAC-BIO was introduced in 2010, while the second-generation TAC-BIO GEN II, was designed in 2015 to be more cost-efficient, as plastic parts were used. Its small, lightweight design allows it to be mounted to vehicles, robots, and unmanned aerial vehicles. The second-generation device could also be utilized as an environmental detector to monitor air quality in hospitals, airplanes, or even in households to detect fungus and mold.
For services to Cricket. Richard Broyd, OBE. Philanthropist. For services to Heritage and Conservation. James Alexander Bullion. Lately Executive Director, Adult Social Services, Norfolk County Council and lately President, Association of Directors of Adult Social Services. For services to Social Care. Robert Geoffrey Burrow, MBE. For services to Motor Neurone Disease Awareness. William Morris Bush. Senior Adviser, Premier League. For services to Sport. Dr. Denise Marie Chaffer. Lately Director, Safety and Learning, NHS Resolution and lately President of the Royal College of Nursing. For services to Patient Safety. Dr. Jung Chang. Author. For services to Literature and to History. David George Crozier. Lately Head, Strategic Partnerships and Engagement, Queen's University Belfast. For services to the Economy. Mark Cutifani. Lately Chief Executive, Anglo American. For services to Investment in the Global Mining Industry. Huw Charles Davies. Lately Chief Executive, British Association for Supported Employment. For services to Employment for Disabled People. Mark William Davies. Director, Windsor Framework Taskforce, Cabinet Office. For Public Service. Dr. Laura Miranda Dawson (Laura Gilbert). Director, Data Science, Prime Minister's Office. For services to Technology and Analysis. Richard George Deverell. Director, Royal Botanic Gardens, Kew. For services to Botanical Science and Conservation. Professor Philip John Diamond. Director General, Square Kilometre Array Observatory. For services to Global Radio Astronomy. Catherine Jane Uttley Dovey.
Sources: en.wikipedia.org
== Side effects == The usual dose of 350 mg is unlikely to elicit prominent side effects other than somnolence, and mild to significant euphoria or dysphoria, but the euphoria is generally short-lived due to carisoprodol's fast metabolization into meprobamate and other metabolites, and is most likely due to carisoprodol's inherent, potent anxiolytic effects, which are far stronger than those of meprobamate, which is often misblamed for the drug-seeking associated with carisoprodol. Carisoprodol has a qualitatively different set of effects from meprobamate (Miltown). The medication is well tolerated and without adverse effects in most patients for whom it is indicated, but in some patients, and/or early in therapy, it can have the full spectrum of sedative side effects and impair the patient's ability to operate a firearm, motor vehicles, and other machinery of various types, especially when taken with medications containing alcohol, in which case alternative medications are considered. The intensity of the side effects of carisoprodol tends to lessen as therapy continues, as with many drugs. Other side effects include dizziness, clumsiness, headache, fast heart rate, upset stomach, vomiting, and skin rash. There are 368 drugs known to interact with carisoprodol, including 28 major drug interactions.
== Medical uses == Setmelanotide is indicated for chronic weight management (weight loss and weight maintenance for at least one year) in people six years and older with obesity due to three rare genetic conditions: pro-opiomelanocortin (POMC) deficiency, proprotein subtilisin/kexin type 1 (PCSK1) deficiency, and leptin receptor (LEPR) deficiency confirmed by genetic testing demonstrating variants in POMC, PCSK1, or LEPR genes considered pathogenic (causing disease), likely pathogenic, or of uncertain significance. Setmelanotide is the first FDA-approved treatment for these genetic conditions. Setmelanotide is not approved for obesity due to suspected POMC, PCSK1, or LEPR deficiency with variants classified as benign (not causing disease) or likely benign or other types of obesity, including obesity associated with other genetic syndromes and general (polygenic) obesity.
== Other uses == Caldwell 8 (NGC 559), an open cluster in Cassiopeia Celestron, 8-inch (200 mm) a Schmidt-Cassegrain telescope C8 carbine, an assault rifle used by Canada and other NATO forces made by Diemaco/Colt Canada C8 Unemployment Indemnity (Shipwreck) Convention, 1920 Elbrus-8C, a Russian 28 Nanometre 8 core microprocessor An international standard paper size (57×81 mm), defined in ISO 216
Sources: en.wikipedia.org
It is a synthetic pentapeptide in the growth hormone secretagogue family. The chain contains five residues, two of which are non-natural amino acids.
It acts as an agonist at the growth hormone secretagogue receptor, also known as the ghrelin receptor. Binding at pituitary somatotroph cells promotes growth hormone release.
Early studies report weaker effects on cortisol, prolactin, and appetite than compounds such as GHRP-6. The size of that difference in humans is not firmly established.
肽键在 214 nm 附近有较强吸收，适合检测缺少芳香侧链的短肽。该波长的基线受流动相组成与梯度影响较大。因此流动相与梯度条件需要固定并完整记录。